Can you take Tecovirimat with Tucatinib?
1 drug interaction and 5 additional warnings found for the following 2 drugs:
- tecovirimat
- tucatinib
Drug interactions
Moderate drug interactions
Moderate:
tucatinib tecovirimat
Applies to: tucatinib and tecovirimat
Tecovirimat may increase the blood levels of tucatinib.
This may increase the risk of serious side effects such as:
- liver injury
- diarrhea
- nausea
- vomiting
- abdominal pain
- seizures
Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications.
It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food/lifestyle interactions
Moderate food/lifestyle interactions
Moderate:
tecovirimat Food/Lifestyle
Applies to: tecovirimat
Food may increase the absorption of tecovirimat when taken orally, which may lead to higher blood levels of the medication.
You should take oral preparations of tecovirimat within 30 minutes after a full meal containing moderate or high fat (approximately 600 calories and 25 g of fat) with 6 to 8 ounces of water.
Disease interactions
4 potential interactions Applies to: 4 conditions, including Hyperkalemia, Liver Disease, Renal Dysfunction, and Smallpox.
Hyperkalemia
Moderate:
tucatinib
Tucatinib has a moderate potential interaction with Hyperkalemia.
Tucatinib contains 60.6 mg potassium per 300 mg dose. This should be taken into consideration especially in patients with hyperkalemia or impaired kidney function who are on a controlled potassium diet.
Liver Disease
Moderate:
tucatinib
Tucatinib has a moderate potential interaction with Liver Disease.
Tucatinib is a hepatotoxic drug. Additionally, its exposure is increased in patients with severe hepatic impairment. This is the reason why the dosage must be reduced in these patients (Child-Pugh C). Consult the manufacturers prescribing information for details on dosage modification.
Renal Dysfunction
Moderate:
tucatinib
Tucatinib has a moderate potential interaction with Renal Dysfunction.
Tucatinib contains 60.6 mg potassium per 300 mg dose. This should be taken into consideration especially in patients with hyperkalemia or impaired kidney function who are on a controlled potassium diet.
Smallpox
Major:
tecovirimat
Tecovirimat has a major potential interaction with Smallpox.
Tecovirimat injection is contraindicated in patients with severe renal dysfunction (CrCl below 30 mL/min).
More resources
tecovirimat
A total of 537 drugs are known to interact with tecovirimat.
- Tecovirimat is in the drug class miscellaneous antivirals.
- Tecovirimat is used to treat the following conditions:
tucatinib
A total of 549 drugs are known to interact with tucatinib.
- Tucatinib is in the drug class HER2 inhibitors.
- Tucatinib is used to treat the following conditions:
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.